As FACS analysis for PDL1, PD1, and CTLA4 was performed in the tumor without isolation of the possible cell types, it is unclear whether determining if detection at different time points is a function of changes in the expression of these markers on the tumor or immune cell populations. The gene discussed is CTLA4; the disease is neoplasm.